EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties

By cineramaMay 18, 2023DeFi

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT ) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM ). Yutiq is a treatment for chronic […]

Click here to view full article

Disclaimer

The statements, opinions and data contained on this site are solely those of the individual authors and contributors and not of the publisher of www.bitcoinisle.com. All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured primarily from third party sources. We make no warranties of any kind in relation to our content and services, including but not limited to accuracy, security and updatedness. No part of the content and services that we provide constitutes financial advice, legal advice or any other form of advice. Any use or reliance on our content and services is solely at your own risk and discretion. You should conduct your own research, review, analyze and verify our content and services before relying on or using them. Participating in cryptocurrency activities is a highly risky endeavor, please therefore consult your financial advisor before making any monetary decisions. No content on our Site is meant to be a solicitation or offer.

EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties

Tags:

Breaking News…

Previous PostWhy Most Cryptocurrency Fraud Cases Take Place in China and the US

Next PostWill Lido benefit from the surge in ETH withdrawals? This data indicates…

Disclaimer